CTOs on the Move

Deciphera

www.deciphera.com

 
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for ...
  • Number of Employees: 100-250
  • Annual Revenue: $500M-1 Billion
  • www.deciphera.com
  • 500 Totten Pond Road 6th Floor
    Waltham, MA USA 02451
  • Phone: 781.209.6400

Executives

Name Title Contact Details
Senthil Gopal
 Director of Cyber Security Profile
Elizabeth Ruhl
 Senior Director, IT Governance, Risk, and Compliance - Information Security Profile
Stephen Aschettino
 Vice President and Chief Information Officer Profile
Stephen Ruddy
 Chief Technical Officer Profile

Similar Companies

Corza Medical

Let’s operate. We prioritize you, so you can prioritize patients. Trusted brands like Quill, Sharpoint, and Tachosil.

Silicycle

ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc. is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Orthopedics of Oklahoma

At Advanced Orthopedics of Oklahoma, our specialty-trained orthopedic doctors and staff deliver the expert, compassionate care needed to heal, recover, and advance throughout Oklahoma in Tulsa, Claremore, Bixby, McAlester.

Viatris

VIATRIS™ is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of approximately ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.